Alarmingly, our dangerous drug lawyers have become aware of a report from the Food and Drug Administration (FDA) indicating that certain generic drugs may not be equivalent to their name-brand counterparts. Because generic drugs are routinely substituted for name-brand drugs in pharmacies, there is a real danger that patients are not getting what they expect.
Concerta and GenericsSufferers of ADHD have long relied on the extended-release form of Ritalin called Concerta to help alleviate the spike-and-wave effects of the fast-acting original form of the drug. Concerta is taken just once a day and lasts for 12 hours. The steady release of the drug helps patients achieve a sustained period of focus so they can succeed in their day-to-day activities.
Last November, the FDA announced that of the three generic options available for Concerta, two did not qualify as equivalents. The generics, made by Mallinckrodt Pharmaceuticals and UCB, did not have the same effectiveness as Concerta and began to wear off much more quickly—after only 7 hours. This posed a serious problem for ADHD patients because these drugs were still only prescribed to be taken once per day.
Despite this, the FDA allowed the companies to continue selling the drugs, giving them 6 months to prove the generics really were equivalent or remove them from the market. This grace period has now lapsed, but the drugs are still being sold as alternatives for Concentra.
Drug companies have a strong interest in keeping generics on the market, sometimes at the expense of patients. If you are suffering from a dangerous or defective drug, you need the help of the experienced lawyers at GoldenbergLaw to help you pursue a personal injury claim.
Please call the defective product attorneys from GoldenbergLaw at (800) 504-0281 today to schedule a free consultation.